Annalisa D'Andrea

Title: Annalisa D'Andrea: Innovator in Radiation Injury Assessment

Introduction

Annalisa D'Andrea is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of radiation injury assessment through her innovative work. Her research focuses on developing methods to qualitatively assess exposure to ionizing radiation.

Latest Patents

Annalisa holds a patent for a biomarker panel designed for dose assessment of radiation injury. This patent includes materials, systems, and methods that allow for the qualitative assessment of a person's exposure to ionizing radiation. The assessment is achieved by measuring the amounts of specific biomarkers, including alpha-1-Antichymotrypsin (ACT), Fms-related tyrosine kinase 3 ligand (Flt3L), and additional proteins. The changes in these biomarkers compared to un-irradiated control reference ranges provide crucial insights into radiation exposure.

Career Highlights

Annalisa D'Andrea is associated with SRI International, where she continues to advance her research and innovations. Her work has garnered attention for its potential applications in medical and safety fields, particularly in assessing radiation exposure in various environments.

Collaborations

Annalisa collaborates with notable colleagues, including David E. Cooper and Robert Balog. Their combined expertise enhances the research and development of innovative solutions in the field of radiation assessment.

Conclusion

Annalisa D'Andrea's contributions to the field of radiation injury assessment through her innovative patent and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in safety and medical applications related to radiation exposure.